ScienceDex / Researcher record
John David O'Neill
- Xylyx Bio, Inc. (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
Start from a Word CV, PubMed IDs or ORCID.
- Early Career
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $665,624 | 2 | #23,577 |
| 2025 | $3,450,061 | 3 | #2,670 |
| 2026 | $3,443,301 | 3 | #5,162 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20242 records
- FY20253 records
- FY2026 · selected3 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 12425690Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award records by amount
NIH award records listing John David O'Neill as a PI. Multi-PI records show the full award amount for context.
- 5R44HL182545-02R44Contact PITranslational development and clinical evaluation of a bioengineered human lung graft for clinical transplantation$1.5Maward amount
- 5R44CA287881-03R44Contact PIMulti-organ metastatic breast cancer cell-based assay platform that models organotropic metastases using patient organoids in human tissue-derived ECMs to accelerate anti-metastatic drug development$1Maward amount
- 5R44DK139877-03R44Contact PILiver fibrosis cell-based assay platform: integrating patient-derived fibrotic liver ECM with primary stellate cells, Kupffer cells, and hepatocytes to accelerate anti-fibrotic drug development$956.6Kaward amount
Award organization
Organizations that administered FY2026 awards listing John David O'Neill as a PI.
FY2026 award administered by Xylyx Bio, Inc. (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardXylyx Bio, Inc.
- 2024$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #2670
- 2025Entered Top 25% NationallyRanked #2670
- 2026$5M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as John David O'Neill.